Glenmark Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) to evaluate antivirial drug favipiravir in clinical trials to treat patients with Covid-19.
Favipiravir is a generic version of Fujifilm Toyama Chemical’s influenza drug Avigan, which holds approval in Japan for treating new influenza virus infections.
Glenmark developed the drug’s API and formulations internally. Following the regulatory approval, the new trial will assess the product in Covid-19 patients with mild to moderate infection.
Around 150 patients will be enrolled for the study. Participants will be given favipiravir plus standard supportive care or only standard supportive care.
Treatment duration of the trial is a maximum of 14 days and the total study duration will be a maximum of 28 days from randomisation.
Glenmark Pharmaceuticals Global R&D executive vice-president Sushrut Kulkarni said: “After having successfully developed the API and the formulations through its in-house R&D team, Glenmark is all geared to immediately begin clinical trials on favipiravir on Covid-19 patients in India.
“The clinical trial will let us know the efficacy of this molecule on Covid-19 patients. If the clinical trials are successful, favipiravir could become a potential treatment for Covid-19 patients.”
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
Prime Minister Shinzo Abe says more than 30 countries have asked Japan for favipiravir (Avigan) to fight Covid 19
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
Kaiser Permanente launches first coronavirus vaccine trial
Corona Fear’s Cure: Chanting from the Bible and the Quran
Can You Chant from the Bible or the Quran to Bliss and Happiness?
Japanese flu drug ‘clearly effective’ in treating coronavirus, says China
Synthetic antibodies might offer a quick coronavirus treatment
The Four Possible Timelines for Life Returning to Normal
The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic
Coronavirus: TB Vaccination Trial Started in Melbourne, Australia
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
All of humanity are intimate neighbors: Coronavirus proves it once again
Praise be to God for the Miracle of Our Immune System
USA: 15-minute coronavirus test is here
Does the Ordinary Soap Kill Coronavirus?
Here’s a list of disinfectants you can use against coronavirus
For the number of cases and epidemiology in each country go to: WorldOMeters
Categories: Health
[Image may contain: 1 person, beard, possible text that says ‘Winds of change? Head of Sudan’s Sovereignty Council: “Israel is not our enemy.” StandWithUs Us’]
Dr. Sam Sussman, Ph.D.
Adjunct Assistant Professor
Department of Psychiatry
Schulich School of Medicine and Dentistry
Western University
Fellow Royal Academy of Medicine in Ireland
World Association of Medical Editors (WAME)
Editorial Board of Armenian Medical Review Journal (AMRJ)
Director Medical Affairs – Regina Physician Group
President and CEO Physicians Canada
http://www.physicianscanada.net
Direct-306-500-5326
Office/Fax- 306-500-5326
if engaged use USA message and e-fax centre 1.208.248.6314
CAUTION: This e-mail message and any attachment(s) contain information that is both confidential and possibly legally privileged. No reader may make any use of its content unless that use is approved. Any opinion, advice or information contained in this e-mail and any attachment(s) is to be treated as interim and provisional only and for the strictly limited purpose of the recipient as communicated.